Opinion: Sexual Dysfunction Matters

Desire and arousal disorders require the biopharmaceutical industry’s attention.

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

FLICKR, JASON SCHLACHETA female commentator on a major cable news channel recently told viewers that the way for men to turn women “on” is to “load the dishwasher.” If it were that simple, therapists would have a great track record of treating low female libido. The dirty secret is they don't. And even more surprising secrets exist in the published research. For example, in 2011, a national survey determined that men who do domestic chores, the kind traditionally performed by women, have significantly less sex than men who don’t, not more.

Though pharmaceutical companies are commonly criticized for “medicalizing” sexual dysfunction, this is not the case. Sexual functioning levels are reduced, and sexual distress is increased among women with sexual desire or arousal problems who have reported a sexual complaint to a doctor—even those who reported otherwise-normal levels of marital satisfaction. Problems with desire and arousal are even recognized by the American Psychiatric Association (APA), which combines the two within sexual interest-arousal disorder (SI-AD). According to the APA, low desire is a problem worth treating when it causes distress and reduces the quality of a woman's life.

People diagnosed with hypoactive sexual desire disorder (HSDD) experience little to no desire for sex, and as a result, significant distress or interpersonal difficulties. Although under-diagnosed, HSDD is highly ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Robert Pyke

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours